Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuronetics, Inc.STIM · Entity 6248 | Director | January 02, 2020 | January 06, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuronetics, Inc.
Report date January 02, 2020 · Filed January 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,472 |
Reported balance
After 2020-01-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 3,062 · Balance 32,472 F1: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2: Mr. Stephen M. Campe is an advisor to an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc. (the "Issuer"). F3: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F4: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer.
F2: Mr. Stephen M. Campe is an advisor to an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc. (the "Issuer").
F3: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose.
F4: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 6, 2020 21:43 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 3,062 | $4.49 | $13,748.38 |
DisclosureSEC source: 0001209191-20-001878 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,472 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · ownership.direct: Mr. Stephen M. Campe is an advisor to an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc. (the "Issuer"). F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 11:41 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 2,500 | $4.23 | $10,575.00 |
DisclosureSEC source: 0001209191-19-058031 · doc4.xml · nonDerivative · entry 2 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,410 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.19 - $4.26, inclusive. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 11:41 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 9,500 | $4.26 | $40,470.00 |
DisclosureSEC source: 0001209191-19-058031 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,910 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.205 - $4.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 13:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 1,656 | $8.30 | $13,744.80 |
DisclosureSEC source: 0001209191-19-051998 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,410 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · ownership.direct: Mr. Stephen M. Campe is an advisor to an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc. (the "Issuer"). F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 21:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 1,099 | $12.51 | $13,748.49 |
DisclosureSEC source: 0001209191-19-040453 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,754 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc. (the "Issuer"). F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:51 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantStock Option (right to buy) · Derivative | 7,347 | $0.00 Strike: $13.43 | $0.00 |
DisclosureSEC source: 0001209191-19-033455 · doc4.xml · derivative · entry 2 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,347 Underlying: Common Stock · 7,347 shares Expires 2029-05-27 F6 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F3 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer"). F4 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F5 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:51 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 3,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-033455 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,655 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer"). F4 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F5 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:32 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 932 | $14.75 | $13,747.00 |
DisclosureSEC source: 0001209191-19-023358 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,932 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer"). F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantStock Option (Right to Buy) · Derivative | 8,767 | $0.00 Strike: $5.22 | $0.00 |
DisclosureSEC source: 0001209191-18-041635 · doc4.xml · derivative · entry 2 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,767 Underlying: Common Stock · 8,767 shares Expires 2028-04-24 F4 · derivative.exercise_date: The performance criterion for vesting of this option was met upon the closing of the Issuer's initial public offering. One twelfth (1/12th) of the shares subject to the option vested or shall vest monthly commencing on March 16, 2018, subject to Reporting Person continuing to provide service through each such date. F1 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer"). F2 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F3 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 10,000 | $17.00 | $170,000.00 |
DisclosureSEC source: 0001209191-18-041635 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer"). F2 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F3 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.